betaFeedback

WorksComputer Science

PathLoop: Self-Evolving Multi-Agent Reasoning for Evidence-Grounded Whole-Slide Image Analysis

Abstract

Analyzing whole-slide images (WSIs) requires combining evidence across tissue regions and spatial scales. Multi-agent systems offer a promising approach to this task. However, existing systems make limited use of molecular evidence, often select visually prominent but less representative regions while overlooking global context, and struggle to reuse experience from previous cases. To address these challenges, we present PathLoop, a self-evolving multi-agent framework that integrates omics data for evidence-grounded WSI analysis. Specifically, PathLoop coordinates visual and omics interpreters across slide, patch, and pixel levels, using molecular signals to guide region selection and combining local tissue details with global slide features. A judgment agent then checks the consistency of the collected evidence against Pathology-Wiki, a knowledge base built from 48 entries across 24 organ systems, and triggers re-examination when the evidence is inconsistent. To reuse past experience, a four-level memory stores reasoning trajectories, practical tips, skills, and tools to guide future cases, forming a loop of evidence collection, review, and memory update. We evaluate PathLoop on four TCGA cohorts with biomarker prediction, survival prediction, and subtype classification. The results demonstrate the effectiveness of PathLoop across these tasks and support its use for evidence-grounded WSI analysis.

Introduction

Pathology is the gold standard for cancer diagnosis, and whole slide images (WSIs) show tissue specimens at gigapixel resolution and are critical for treatment decisions [1, 2]. However, owing to the complexity and fine-grained nature of pathological data, an ideal model must identify sparse diagnostic clues within extremely large images while navigating and interacting across multiple regions, posing

Figure 1. Comparison between existing WSI analysis paradigms and PathLoop. (A) WSI-only methods rely primarily on visually salient ROIs and may miss diagnostically informative but visually inconspicuous regions. (B) Existing WSI–omics methods fuse separately encoded visual and molecular features, without using omics to guide ROI selection. (C) PathLoop leverages omics-informed planning to select task-relevant ROIs and introduces a feedback loop from prediction to planning for iterative refinement.

substantially greater challenges than other medical imaging tasks [3]. Unlike the single-pass image-reading process commonly performed by radiologists, pathological diagnosis is inherently a long-horizon, interactive cognitive process. Collaborative multi-agent systems therefore constitute a natural paradigm for modeling this process and have recently attracted increasing attention [4, 5].

Existing pathology multi-agent systems largely emulate the workflow of pathologists: they first scan slides at low magnification to retrieve initial regions of interest (ROIs), progressively focus on these regions at higher magnifications, and conduct evidence retrieval under the guidance of specific diagnostic queries [6, 7, 8, 9, 10]. Their performance therefore depends on whether the selected regions contain evidence relevant to the target. This is difficult in heterogeneous tumors, where visually prominent regions are not always the most informative. Mainstream approaches can be broadly divided into two categories: (i) weakly supervised multiple-instance learning (MIL) aggregates patches under slide-level labels and the attention is post-hoc and does not verify evidence sufficiency [11, 12]; (ii) although VLM-based WSIs readers make the retrieval process explicit, they rely primarily on prompt-level guidance and lack molecularly informed retrieval priors, making them prone to selecting visually salient regions that are irrelevant to the diagnostic endpoint [13, 14]. Crucially, a related challenge is to retain slide-level context when interpreting local tissue details, since evidence from an isolated region may not reflect patterns across the full slide. [15].

Another limitation is that current pathology multi-agent systems cannot effectively leverage omic information for evidence-grounded diagnosis. Omic data and histopathological morphology provide complementary perspectives on tumor biology and evolution: morphological insights reveal tissue architecture and microenvironment, while molecular features from omics elucidate the underlying biological mechanisms [16, 17]. However, most existing systems operate exclusively on images. The few multimodal WSI-omics fusion methods [18, 19, 20] treat omics merely as a parallel feature stream or supplementary text. Omics neither guides region retrieval nor verifies the completeness of the retrieved evidence, resulting in final predictions with limited biological relevance and insufficient accuracy.

A third challenge is that pathology multi-agent systems still analyze each test case independently, overlooking valuable diagnostic and prognostic experience accumulated from previous cases. From a cognitive perspective, clinical expertise develops through cumulative cross-case experience: prior cases are recalled, compared, and progressively abstracted into reusable patterns that guide future decisions [21]. By integrating semantic knowledge, episodic memory, and procedural knowledge, this cognitive process enables clinicians to adapt to novel scenarios that are not fully covered by training data or textbooks. Therefore, current agents require a new evolutionary paradigm that integrates experiential learning with explicit reasoning trajectories to enable effective WSIs analysis.

To address these challenges, we propose PathLoop, a self-evolving, evidence-grounded, omics-enhanced multi-agent framework for WSI analysis. The framework comprises four collaborative agents: Planning, Execution, Judgment, and Persist, which decompose long-horizon WSI analysis into specialized cognitive stages to mitigate cognitive overload. The Planning Agent interprets the task, identifies the required data modalities, retrieves relevant prior experience, and assigns subtasks to specialist modules. The Execution Agent coordinates visual and omics experts across slide, patch, and pixel levels, using molecular signals to guide region selection and integrating slide-level context with fine-grained visual evidence. The Judgment Agent evaluates the consistency of the collected evidence against Pathology-Wiki and triggers re-examination when inconsistencies arise, thereby enabling evidence-grounded self-correction. Finally, the Persist Agent maintains a four-level memory of reasoning trajectories, practical tips, skills, and tools [22, 23, 24]. It updates this memory using task outcomes and post hoc diagnostic ground truth, enabling subsequent cases to benefit from prior experience without parameter updates. Together, these agents form a closed loop of evidence collection, verification, and experience reuse.

Our main contributions are summarized as follows:

  • We propose PathLoop, a self-evolving, evidence-grounded, omics-enhanced multi-agent framework for computational pathology, which decomposes long-horizon WSIs diagnosis into procedural cognitive steps via Planning, Execution, Judgment, and Persist Agents, alleviating cognitive overload. To our knowledge, it is the first pathology agent that uses omics to guide region selection and accumulates reusable experience across cases.

  • We design an omics-guided retrieval mechanism that uses molecular signals to select diagnostically relevant regions, and a four-level memory that improves future cases from past experience without parameter updates.

  • We curate and publicly release Pathology-Wiki, constructed from 48 entries across 24 organ systems. On four TCGA cohorts covering biomarker prediction, survival prediction, and subtype classification, PathLoop consistently outperforms pathology MLLMs, pathology agents, and WSI–omics fusion methods.

Related Work

WSIs Analysis Techniques

With the development of LLMs, WSIs analysis has evolved from MIL toward a new paradigm based on MLLMs. Recent pathology-specific MLLMs have demonstrated sub stantial potential for WSIs analysis. CONCH [25], MUSK [26], and PLIP [27] achieve strong performance in patch retrieval through vision–language contrastive learning, while Quilt-LLaVA [28] and Hepato-LLaVA [29] further incorporate visual evidence into open-ended descriptions, exhibiting enhanced reasoning capabilities. However, constrained by limited context windows, these models only local patches. To overcome this limitation, SlideChat [30], WSI-LLaVA [13], and WSI-SUM [31] attempt to analyze complete WSIs through patch aggregation, yet they remain insufficient in providing well-grounded visual reasoning and comprehensive diagnostic planning. More fundamentally, existing MLLMs typically process pathological inputs through a fixed feed-forward pipeline, which is inherently inconsistent with the dynamic, interactive, and multiscale diagnostic workflow of expert pathologists.

Pathology Multi-Agent Systems

Gigapixel WSIs analysis is inherently complex, requiring cross-scale navigation and cross-region interaction. Collaborative multi-agent systems thus offer a promising paradigm for such long-horizon diagnostic processes. For instance, SlideSeek [32] coordinates a supervisor, multiple parallel explorers, and a reporter for autonomous whole-slide analysis.

sis. CPathAgent [7] simulates pathologists’ multiscale reasoning through a three-stage navigation–reasoning pipeline. PathAgent [9] constructs explicit thought chains from sequential observations and decisions for interpretable analysis. SurvAgent [18] combines LMScreen, CoSMining, and ConfMining across scales for survival prediction, forming an effective multi-agent framework.

PathLoop addresses these challenges by combining omics-guided region retrieval, cross-scale visual analysis, evidence checking against Pathology-Wiki, and memory updates across cases. Rather than treating region selection, evidence review, and experience reuse as separate steps, PathLoop brings them into a single multi-agent workflow for WSI analysis.

Method

PathLoop decomposes WSI analysis into four stages and each handled by a dedicated agent (Figure 2). We describe the four agents in turn.

PathLoop framework

Figure 2. The PathLoop framework comprises four alternating phases. The Planning Agent analyzes the input and formulates a plan by drawing on historical experience. The Execution Agent performs slide-, patch-, and pixel-level processing and integrates omics data. The Judgment Agent conducts a consistency review against Pathology-Wiki. Finally, the Persist Agent builds a four-level memory from past trajectories, which is retrieved to guide reasoning in future cases.

Planning Agent

Given the input WSI image II, gene data GG, and user query QQ, the Planning Agent based on GPT-5.5 [33] first reformulates the query into a structured prompt PP, and dynamically dispatches relevant expert subsets by mapping (I,P)(I, P) and (G,P)(G, P). The system maintains a four-level memory bank, storing L={traj,tip,skill,tool}\mathcal{L} = \{\mathrm{traj},\mathrm{tip},\mathrm{skill},\mathrm{tool}\}, where each MtlM_t^l stores type-ll memories: Mt=Mttraj∪Mttip∪Mtskill∪MttoolM_t = M_t^{\mathrm{traj}} \cup M_t^{\mathrm{tip}} \cup M_t^{\mathrm{skill}} \cup M_t^{\mathrm{tool}}, and the specific implementation will be described in the Persist Agent section. We form the query zt=[Pt:It:Gt]z_t = [P_t : I_t : G_t], and retrieve the top-KK candidates from each memory level through embedding similarity:

Ctl=TopK⁡m∈Mtlsim⁡(ϕ(zt),ϕ(m)),Ct=⋃l∈LCtl.(1)C_t^l = \operatorname{TopK}_{m \in M_t^l} \operatorname{sim}(\phi(z_t), \phi(m)), \qquad C_t = \bigcup_{l \in\mathcal{L}} C_t^l. \tag*{(1)}

where ϕ(⋅)\phi(\cdot) is the embedding encoder, sim⁡(⋅)\operatorname{sim}(\cdot) denotes cosine similarity, and TopK returns the KK memories with the highest scores. The selector then compresses CtC_t into the memory context presented to the agent:

Stl=Sel⁡θ(xt,Ctl),St=⋃l∈LStl,ct=Fmt⁡(St).(2)S_t^l = \operatorname{Sel}_{\theta}(x_t, C_t^l), \qquad S_t = \bigcup_{l \in\mathcal{L}} S_t^l, \qquad c_t = \operatorname{Fmt}(S_t). \tag*{(2)}

Based on ztz_t and ctlc_t^l, the VLM generates a disease-specific diagnostic plan containing multiple reasoning steps P={P1,P2,⋯ ,Pn}\mathcal{P} = \{P_1, P_2, \cdots, P_n\}. Each step Pi∈PP_i \in\mathcal{P} is represented as:

Pi:ri=⟨kri,vri⟩=⟨kri,t(voi)⟩,t∈T.(3)P_i: r_i = \langle k_{r_i}, v_{r_i} \rangle= \langle k_{r_i}, t(v_{o_i}) \rangle, \qquad t \in\mathcal{T}. \tag*{(3)}

The processed object oi=(ko,oo)o_i = (k_{o}, o_{o}) and the result ri=(kr,Or)r_i = (k_r, O_r) are represented as key-value pairs, where the key (kok_o or krsk_{r_s}) specifies the data attribute, and the value (UoU_o or UrsU_{r_s}) contains the actual data. The specific implementation is described in [34].

Execution Agent

Slide Level: Given a WSI II, we downsample it to I2.5I_{2.5} and compute a 768-dimensional slide-level embedding ss using the TITAN [35] encoder, summarizing the global scan.

Patch Level: We use a sliding window to partition WSIs into 10×10\times patches and encode them with CONCHv1.5 [25] as X=PatchEncoder⁡(P)X = \operatorname{PatchEncoder}(P), where P∈RN×3×2048×2048P \in\mathbb{R}^{N \times3 \times2048 \times2048} and X∈RN×CX \in\mathbb{R}^{N \times C}. Following [31], we identify redundant patch embeddings by their reconstructability from unmasked ones. We partition XX into KK clusters via K-means, obtaining Xk=MkXX_k = M_kX. Within each cluster, we randomly mask a subset M⊂XkM \subset X_k and feed the unmasked tokens Xk∖MX_k \setminus M with positional encodings PvP_v to an encoder: Z=Encoder⁡(Xk∖M+Pv)Z = \operatorname{Encoder}(X_k \setminus M + P_v). A lightweight decoder reconstructs the masked embeddings from ZZ, learnable mask tokens mm, and their positional encodings PmP_m: X^=Decoder⁡(Z,m,Pm)\hat{X} = \operatorname{Decoder}(Z, m, P_m), with X^={ei}\hat{X} = \{e_i\} maintaining the original order. Path-R1 then analyzes patch sequence representativeness and generates preliminary reports {Ri}i=1n\{R_i\}_{i=1}^{n}, yielding selected lesion ROI records PselectvP_{\mathrm{select}}^v.

Following [36], given DNA methylation vector xdna∈RFd\mathbf{x}_{dna} \in\mathbb{R}^{F_d} and miRNA vector xmirna\mathbf{x}_{mirna}, we standardize them and project to P=50P = 50 pathways using predefined binary masks Mdna∈RP×FdM_{dna} \in\mathbb{R}^{P \times F_d} (MSigDB Hallmark) and Mmirna∈RP×FmM_{mirna} \in\mathbb{R}^{P \times F_m} (miRTarBase). The pathway score is sp=spdna+spmirnas_p = s_p^{dna} + s_p^{mirna}, with spdna=−∑iMdna,ipxidna∑iMdna,ip+ϵs_p^{dna} = -\frac{\sum_i M_{dna,i}^{p} x_i^{dna}}{\sum_i M_{dna,i}^{p} + \epsilon} and spmirnas_p^{mirna} analogous. The negative sign indicates downregulation, and the denominator normalizes by pathway member count.

We define a sparse matrix W∈RK×PW \in\mathbb{R}^{K \times P} (K=16K = 16) with ℓ1\ell_1 row normalization, whose rows correspond to morphological axes (e.g., mitotic activity, necrosis, stromal fibrosis) and columns to pathways. Entries are set based on WHO terminology and biological associations, without optimization against endpoint labels. The intention vector is computed as

m=ℓ2-normalize(ReLU⁡(Ws))∈RK,(4)\mathbf{m} = \ell_2\text{-normalize}(\operatorname{ReLU}(W\mathbf{s})) \in\mathbb{R}^{K}, \tag*{(4)}

where s=[s1,…,sP]⊤\mathbf{s} = [s_1, \ldots, s_P]^\top. ReLU suppresses negative contributions, and ℓ2\ell_2 enables cosine similarity comparisons.

From m\mathbf{m}, a committee of three role-conditioned LLMs generates a keyword set QQ (15–40 terms) to guide endpoint-aware retrieval. We retrieve 256 ×\times 256 px patches at 10×10\times, encode them into 1024-d ℓ2\ell_2-normalized embeddings with UNI, and apply MiniBatchKMeans (k=300k = 300) to select the patch nearest each centroid as a representative. Each representative is captioned by Qwen3-VL-8B at 10×10\times, producing structured captions caption10^{10} covering tumor architecture, stroma and necrosis. A TF-IDF vectorizer ϕ\phi is fit on the 300 captions per slide. We rank patches by score10(pi)=cos⁡(ϕ(Q),ϕ(capi10))^{10}(p_i) = \cos(\phi(Q), \phi(\mathrm{cap}_i^{10})), select the Top-64 to form an 8×88 \times8 mosaic for VLM inference in a single forward pass. Sub-patches P20=⋃kPk20P_{20} = \bigcup_k P_k^{20} are extracted via cross-modal similarity filtering and magnified to 20×20\times for fine-grained review.

Pixel Level: For ROIs, we magnify them to ×20\times20 for fine-grained assessment. To integrate the global CLS token, we train a lightweight projector: from the slide-level embedding s\mathbf{s}, a two-layer MLP projects it to a global token g=MLP⁡(s)\mathbf{g} = \operatorname{MLP}(\mathbf{s}) in Qwen3-VL-8B’s token space. We inject this descriptor by reserving a special marker token before the ROI images and overwriting its embedding with g\mathbf{g} via a forward hook, leaving sequence lengths, M-RoPE positions, and the attention mask unchanged. The CLS token then co-attends with the fine-grained ROI patch tokens, supplying whole-slide context to the zoomed reading. This stage produces the final report.

Judgment Agent

The Judgment Agent verifies diagnoses from the Execution Agent by consulting a structured Pathology-Wiki rather than relying on embedding-based retrieval. The wiki is constructed from TCGA reports and PubMed, and contains 48 subtype codes across 24 organ systems and 27 tumor types; after merging codes that share the same content, this corresponds to 43 distinct JSON pages. Each page follows a standardized schema with fields such as Essential Features, Microscopic Description, Immunohistochemistry, and Differential Diagnosis. Figure 3 summarizes the scope, content structure, and diagnostic utility of Pathology-Wiki.

Given a diagnostic text dd, the best-matching subtype cc is resolved via lexical routing:

resolve⁡(d)=arg⁡max⁡c∈W s(d,c),(5)\operatorname{resolve}(d) = \underset{c \in\mathcal{W}}{\arg\max}\ s(d,c), \tag*{(5)}

where the matching score s(d,c)s(d,c) is a weighted sum: 6 points for a name/alias match, 2 for an organ match, and 1 per overlapping term. The system retrieves the diagnostic card card⁡(c)\operatorname{card}(c) and its differential-diagnosis cards, then prompts the language model with the concatenation of the original description, matched card, and differential cards. The model outputs a JSON verdict containing pass/revise, supported, missing, preferred, diff, corrected, and citations; all claims cite the knowledge base verbatim. When inference is unavailable, a deterministic fallback is applied: if the top-matching score exceeds τroute\tau_{\mathrm{route}} and no same-organ competitor lies within Δ\Delta points, the verdict is pass; otherwise revise. If revised, the wiki-based feedback is returned to the Execution Agent, triggering a 20× intensified re-examination and diagnosis regeneration. This forms a Judgment-Execution closed loop, capped at LL iterations, which leverages structured knowledge to correct overconfident predictions and misclassifications.

Persist Agent

The agent maintains a four-level memory of trajectories, tips, skills, and tools. Trajectories form a slide-level tree; the optimal path maximizes leaf value:

best_path⁡=arg⁡max⁡ρ V(leaf⁡(ρ)),V(n)=max⁡ℓ≤n o(ℓ).(6)\operatorname{best\_path} = \underset{\rho}{\arg\max}\ V(\operatorname{leaf}(\rho)), \quad V(n) = \underset{\ell\le n}{\max}\ o(\ell). \tag*{(6)}

Memory operations consist of SELECT, WRITE, and MANAGE stages. In SELECT, coarse retrieval first applies global embeddings, then retrieves top-KK by cosine similarity over flattened memory; matched memories are injected for reference only to avoid contamination. After execution, WRITE distills the current decision process into the memory structure. Every QQ runs, MANAGE scores each memory item by V(m)=α⋅γ(m)⋅A^(m)V(m) = \alpha\cdot\gamma(m) \cdot\hat{A}(m), merges near-duplicates and removes obsolete content for compactness.

The outcome signal is o=cos⁡(Etext(d),Etext(GT))o = \cos(E_{\mathrm{text}}(d), E_{\mathrm{text}}(\mathrm{GT})), with a consistency fallback when ground truth is absent. Credit assignment uses a controlled-candidate advantage A^(m)=mean⁡(o∣m retrieved)−mean⁡(o∣m not retrieved)\hat{A}(m) = \operatorname{mean}(o \mid m\ \text{retrieved}) - \operatorname{mean}(o \mid m\ \text{not retrieved}), which yields near-zero credit for alwaysretrieved memories, preventing erroneous assignment. Only memories that improve outcome are reinforced, creating a cross-slide knowledge loop without parameter updates.

MethodModalityER (AUC)PR (AUC)HER2 (AUC)Subtype (AUC)Risk (C-index)
▼ Conventional Methods
SNNO0.952±0.0210.952 \pm0.0210.885±0.0350.885 \pm0.0350.725±0.0450.725 \pm0.0450.958±0.0150.958 \pm0.0150.620±0.0450.620 \pm0.045
SNNTransO0.958±0.0180.958 \pm0.0180.912±0.0280.912 \pm0.0280.765±0.0380.765 \pm0.0380.970±0.0120.970 \pm0.0120.645±0.0380.645 \pm0.038
ABMILW0.885±0.0320.885 \pm0.0320.755±0.0450.755 \pm0.0450.655±0.0520.655 \pm0.0520.955±0.0220.955 \pm0.0220.590±0.0520.590 \pm0.052
TransMILW0.901±0.0280.901 \pm0.0280.763±0.0410.763 \pm0.0410.687±0.0480.687 \pm0.0480.972±0.0150.972 \pm0.0150.615±0.0480.615 \pm0.048
MCATO+W0.975±0.0220.975 \pm0.0220.935±0.0310.935 \pm0.0310.768±0.0420.768 \pm0.0420.975±0.0180.975 \pm0.0180.665±0.0420.665 \pm0.042
MOTCatO+W0.962±0.0190.962 \pm0.0190.948±0.0250.948 \pm0.0250.795±0.0360.795 \pm0.0360.980±0.0140.980 \pm0.0140.685±0.0350.685 \pm0.035
SurvPathO+W0.941±0.0150.941 \pm0.0150.957±0.0220.957 \pm0.0220.815±0.0320.815 \pm0.0320.975±0.0120.975 \pm0.0120.705±0.0300.705 \pm0.030
▼ Pathology Foundation Models
CONCHW0.845±0.0040.845 \pm0.0040.758±0.0070.758 \pm0.0070.574±0.0140.574 \pm0.0140.772±0.0050.772 \pm0.0050.612±0.0110.612 \pm0.011
TITANW0.857±0.0090.857 \pm0.0090.764±0.0090.764 \pm0.0090.633±0.0160.633 \pm0.0160.814±0.0040.814 \pm0.0040.642±0.0120.642 \pm0.012
QuiltNetW0.765±0.0120.765 \pm0.0120.674±0.0130.674 \pm0.0130.611±0.0250.611 \pm0.0250.714±0.0100.714 \pm0.0100.560±0.0150.560 \pm0.015
PLIPW0.790±0.0110.790 \pm0.0110.713±0.0050.713 \pm0.0050.598±0.0150.598 \pm0.0150.727±0.0060.727 \pm0.0060.556±0.0070.556 \pm0.007
▼ Proprietary MLLMs
GPT-5.5O+W0.945±0.0350.945 \pm0.0350.880±0.0450.880 \pm0.0450.710±0.0550.710 \pm0.0550.950±0.0250.950 \pm0.0250.610±0.0650.610 \pm0.065
Gemini-2.5ProO+W0.932±0.0230.932 \pm0.0230.871±0.0540.871 \pm0.0540.791±0.0150.791 \pm0.0150.948±0.0290.948 \pm0.0290.649±0.0650.649 \pm0.065
▼ Medical Agents
MDAgentO+W0.962±0.0250.962 \pm0.0250.915±0.0380.915 \pm0.0380.755±0.0480.755 \pm0.0480.972±0.0180.972 \pm0.0180.640±0.0500.640 \pm0.050
PathLoop (Ours)O+W0.964±0.0040.964 \pm0.0040.958±0.0160.958 \pm0.0160.854±0.0070.854 \pm0.0070.983±0.0220.983 \pm0.0220.735±0.0050.735 \pm0.005

Table 1. Comparison with SOTA methods on multi-task prediction on TCGA-BRCA. AUC for ER/PR/HER2, macro AUC for Subtype, and C-index for Risk. Modality denotes the input data: O for omics, W for WSI, and O+W for both. The best and second-best results are highlighted in bold and underlined, respectively.

Experiments

Experimental Dataset and Setup

We evaluated PathLoop on four TCGA cohorts: BRCA, LUAD, BLCA, UCEC. We evaluate six tasks: ER, PR, HER2, subtype classification, survival risk prediction, and report generation accuracy. Report generation accuracy is assessed using CLIP-cos, BLEU-1, BLEU-4, METEOR, and ROUGE-L. Labels are derived from TCGA clinical annotations; samples with missing or uncertain receptor status are excluded per task. Baselines include omics-only methods (SNN [37] and SNNTrans [38]), WSI-only MIL methods (ABMIL [11] and TransMIL [12]), multimodal fusion methods (MCAT [20], MOTCat [39], and SurvPath [19]), pathology VLM/agent methods (MDAgent [40] and WSI-Agent [6]), and general-purpose commercial models (GPT-5.5, Gemini-2.5Pro). The projector is trained on an A100 GPU.

Comparisons with Base Models

Multi-task prediction and report generation (Table 1). For multi-task prediction, PathLoop attains the best PR

MethodAlignmentNLP Metrics
CLIP-cosBLEU-1BLEU-4METEORROUGE-L
w/ Projector0.660.530.140.170.19
w/o Projector0.530.430.020.040.06
Quilt-LLaVA0.4850.470.030.070.06
HistGen0.510.080.010.100.10
MDAgents0.460.010.000.050.06
MedAgents0.530.150.030.110.08
WSI-Agent0.580.470.090.110.14

Table 2. Ablation study of the projector module and comparative experiments on language generation performance.

(0.958), HER2 (0.854), Subtype (0.983), and Risk (0.735) among all compared methods. Relative to the previous strongest baseline SurvPath, it improves HER2 by 0.039 (from 0.815 to 0.854) and Risk by 0.030 (from 0.705 to 0.735), and further surpasses SurvPath on Subtype by 0.008 (0.983 vs. 0.975). For ER, MCAT achieves the highest AUC (0.975), while PathLoop obtains 0.964, ranking second and outperforming every other baseline.

In the report generation and alignment experiment (Table 2), adding the projector improves the CLIP-cosine alignment score from 0.53 to 0.66. The gains in NLP metrics are also substantial: BLEU-1 rises from 0.43 to 0.53, BLEU-4 from 0.02 to 0.14, METEOR from 0.04 to 0.17, and ROUGE-L from 0.06 to 0.19. PathLoop further outperforms all existing report generation methods on every metric; relative to the strongest baseline WSI-Agent, it improves CLIP-cos by 0.08 (0.66 vs. 0.58), BLEU-4 by 0.05 (0.14 vs. 0.09), METEOR by 0.06 (0.17 vs. 0.11), and ROUGE-L by 0.05 (0.19 vs. 0.14). These results indicate that the projector effectively bridges visual and textual modalities for pathology report generation.

To verify that PathLoop generalizes beyond a single cohort, we additionally evaluate survival risk prediction on BLCA, LUAD, and UCEC (Table 3). PathLoop achieves the best mean C-index (0.695) across the four cohorts, ranking first on BRCA and UCEC and second on LUAD, indicating that evidence-grounded reasoning transfers across cancer types rather than overfitting to the primary cohort.

Table 3. Comparison of survival risk prediction (C-index) on four TCGA cohorts. The best and second-best results are highlighted in bold and underlined, respectively.

MethodBLCALUADBRCAUCECMean
SNN0.541±0.0160.541 \pm0.0160.539±0.0690.539 \pm0.0690.620±0.0450.620 \pm0.0450.493±0.0690.493 \pm0.0690.5480.548
SNNTrans0.646±0.0430.646 \pm0.0430.634±0.0490.634 \pm0.0490.645±0.0380.645 \pm0.0380.632±0.0320.632 \pm0.0320.6390.639
TransMIL0.576±0.0650.576 \pm0.0650.615±0.0340.615 \pm0.0340.615±0.0480.615 \pm0.0480.549±0.0440.549 \pm0.0440.5890.589
E2E-CONCH0.653±0.0240.653 \pm0.0240.705±0.0290.705 \pm0.0290.660±0.0140.660 \pm0.0140.614±0.0760.614 \pm0.0760.6580.658
MCAT0.645±0.0530.645 \pm0.0530.636±0.0430.636 \pm0.0430.665±0.0420.665 \pm0.0420.634±0.0180.634 \pm0.0180.6450.645
MOTCat0.674±0.0240.674 \pm0.0240.674±0.0360.674 \pm0.0360.685±0.0350.685 \pm0.0350.667±0.0510.667 \pm0.0510.6750.675
DPSurv0.625±0.0370.625 \pm0.0370.667±0.0380.667 \pm0.0380.654±0.0250.654 \pm0.0250.594±0.0270.594 \pm0.0270.6350.635
OTSurv0.637±0.0280.637 \pm0.0280.638±0.0490.638 \pm0.0490.621±0.0120.621 \pm0.0120.643±0.0250.643 \pm0.0250.6350.635
SurvAgent0.683±0.0220.683 \pm0.0220.676±0.0360.676 \pm0.0360.695±0.0130.695 \pm0.0130.676±0.0520.676 \pm0.0520.6830.683
PathLoop0.671±0.0370.671 \pm0.0370.691±0.0420.691 \pm0.0420.735±0.0050.735 \pm0.0050.682±0.0440.682 \pm0.0440.6950.695

Table 3.

Survival stratification (Figure 4). Kaplan–Meier analysis shows that Gemini-2.5-Pro and MDAgent fail to produce a significant separation between high- and low-risk groups (p>0.05p > 0.05). In contrast, PathLoop achieves a statistically significant stratification. This indicates that our method captures stronger and more robust prognostic signals from WSIs and omic features, surpassing both general-purpose and agent-based alternatives in discriminative power.

Figure 4. Kaplan-Meier Analysis of predicted high-risk and low-risk groups. Shaded areas refer to the confidence intervals.

Ablation Study

Module ablations (Table 4). Removing any single component degrades performance below the full model’s C-index of 0.735, confirming that all four agents contribute to the final prediction. The omics branch is the largest contributor: without it, the C-index falls to 0.642, underscoring the value of molecular priors for prognostic reasoning. We attribute this drop to retrieval quality: without molecular priors, region selection reverts to visual saliency and misses inconspicuous but prognostically relevant areas, such as stromal reaction or subtle architectural atypia. Judgment follows closely, with performance dropping to 0.648 when Pathology-Wiki verification is removed, indicating that knowledge-grounded correction recovers errors that visual evidence alone cannot. Without it, overconfident draft diagnoses pass unchallenged, as exemplified by the case in Figure 5. Removing the projector yields 0.676, showing that slide-level context complements pixel-level reading. Memory and the CLS token offer smaller but consistent gains, dropping to 0.703 and 0.704 when removed.

Table 4. Ablation study of the agent modules on TCGA-BRCA. The full model achieves a C-index of 0.735.

ModuleSettingC-index
Planningw/o CLS token0.704
Executionw/o Projector0.676
Executionw/o Omics0.642
Judgmentw/o Pathology-Wiki0.648
Persistw/o Memory0.703

Table 4.

Figure 5. Explainability analysis through visualization on case TCGA-C8-A1HK.

Impact of concept embedding WW and number of concepts KK (Table 5). Our learned WoursW_{\mathrm{ours}} yields the best ER, PR, HER2, and Risk. Corrupting WW with Gaussian noise (WnoiseW_{\mathrm{noise}}) severely degrades HER2 and Risk, although ER and PR remain relatively robust. Shuffling the pathway assignments (WshuffleW_{\mathrm{shuffle}}) retains strong Subtype performance but reduces HER2 by 0.187 and Risk by 0.051, supporting that WW encodes structured biological knowledge rather than arbitrary connectivity. Using a random WW degrades all endpoints, with a milder HER2 drop but still markedly below our learned representation. Scaling the number of concepts from K=8K=8 to K=32K=32 brings consistent gains: K=32K=32 achieves the highest ER, HER2, and Risk, while K=16K=16 reaches the best PR and Subtype. K=8K=8 severely underperforms, indicating that too few concepts merge clinically distinct patterns and hurt all tasks.

Table 5. Ablation study of different settings on TCGA-BRCA.

SettingERPRHER2SubtypeRisk
WoursW_{\mathrm{ours}}0.9640.9580.854<u>0.983</u>0.735
WnoiseW_{\mathrm{noise}}0.9390.8970.578<u>0.975</u>0.685
WdropW_{\mathrm{drop}}0.9350.8610.7700.900<u>0.725</u>
WshuffleW_{\mathrm{shuffle}}0.912<u>0.897</u>0.6670.9890.684
WrandomW_{\mathrm{random}}0.8980.764<u>0.797</u>0.8930.686
K=8K=80.5770.7450.5230.6590.563
K=16K=160.964<u>0.958</u>0.854<u>0.983</u>0.735
K=32K=32<u>0.875</u>0.962<u>0.673</u>0.989<u>0.686</u>

Table 5.

In Table 6, we examine the regularization strength CC.

LogReg CCERPRHER2SubtypeRisk
0.10.9640.9580.854<u>0.983</u>0.735
0.5<u>0.954</u>0.958<u>0.804</u>0.9310.691
1.00.8810.9580.8030.992<u>0.698</u>

Table 6. Sensitivity analysis of logistic regression.

C=0.1C=0.1 yields the best overall Risk and HER2; increasing CC to 1.0 improves Subtype (0.992) but reduces HER2 by 0.051 and Risk by 0.037, while PR is insensitive to CC. All reported results use C=0.1C=0.1; the Cox model is kept with default L2 penalty, and predictions remain stable across the tested hyperparameter range.

Visualization

Figure 5 illustrates the closed-loop collaboration of planning, execution, judgment, and persistence agents. The Planning Agent retrieves memories S3 (0.639) and D8 (0.549) and generates an 8-step plan. The Execution Agent screens at ×2.5, projects the 768-dim TITAN vector to a global CLS token, and narrows 63 suspicious patches to 8 (set AA). The Gene Interpreter encodes methylation/miRNA into a 16-dim morphological intent and retrieves set BB; the intersection A∩BA \cap B yields 8 patches. Molecular priors assign high scores to apoptotic bodies, desmoplasia, mucin, architectural atypia, and vascular invasion, yet patch–gene cosine similarity is only cos⁡(m,v)=0.2609\cos(m,v)=0.2609, indicating weak visual evidence. The fused global token and ×20 patches produce a draft diagnosis “desmoplastic breast carcinoma”. Visual consistency gating passes (c=0.836c=0.836), but the Judgment Agent audits against a pathology knowledge base, finds insufficient support for tubule formation and desmoplasia, and issues REVISE. After re-examination, consistency drops to c=0.751c=0.751, while Judgment again demands revision. Reconciling visual evidence with molecular priors, the system matches the case to invasive ductal carcinoma with confidence 0.80 and refines the diagnosis to “invasive ductal carcinoma with desmoplastic features. tures”. The Persist Agent stores the corrected reasoning trace, skills, tools, and decisions into persistent memory. This case demonstrates that visual self-consistency can retain a plausible but poorly supported diagnosis, whereas multi-agent evidence auditing identifies cross-modal inconsistency, corrects the diagnosis, and converts the correction into reusable long-term experience.

Conclusion

In this work, we proposed PathLoop, a self-evolving multi-agent framework that couples omics-guided region retrieval with cross-scale visual analysis, verifies diagnoses against Pathology-Wiki, and consolidates past cases into a four-level memory. Experiments establish state-of-the-art performance, offering an evidence-grounded route to continually improving whole-slide image analysis.

References

  1. [1]Jincheng Li, Danyang Dong, Menglin Zheng, Jingbo Zhang, Yueqin Hang, Lichi Zhang, and Lili Zhao. High-precision mixed feature fusion network using hypergraph computation for cervical abnormal cell detection. In International Conference on Medical Image Computing and Computer-Assisted Intervention, 2025. 1arxiv.org/abs/2508.16140
  2. [2]Jincheng Li, Yuzhi He, Yihui Zhan, Xinmei Zhang, Yifei Sun, Zelin Liu, Lichi Zhang, Minye Shao, and Lili Zhao. Two-stage cross-domain cervical abnormality screening with cytopathological image synthesis and knowledge distillation. 2026. 1arxiv.org/abs/2606.27678
  3. [3]Haotian Jiang, Jiangdong Cai, Zhenrong Shen, Mengjie Xu, Manman Fei, Haolin Huang, Xinyu Wang, Rui Bi, Dinggang Shen, Lichi Zhang, and Qian Wang. Unicas: A foundation model for cervical cytology screening. Cell Reports Medicine, 7, 2026. 2DOI
  4. [4]Yuxuan Sun, Chenglu Zhu, Sunyi Zheng, Kai Zhang, Zhongyi Shui, Xiaoxuan Yu, Yizhi Zhao, Honglin Li, Yunlong Zhang, Ruojia Zhao, Xinheng Lyu, and Lin Yang. Pathasst: A generative foundation ai assistant towards artificial general intelligence of pathology. In AAAI Conference on Artificial Intelligence, 2023. 2arxiv.org/abs/2305.15072
  5. [5]Yuxuan Sun, Yunlong Zhang, Yixuan Si, Chenglu Zhu, Zhongyi Shui, Kai Zhang, Jingxiong Li, Xingheng Lyu, Tao Lin, and Lin Yang. Pathgen-1.6: 1.6 million pathology image-text pairs generation through multi-agent collaboration. ArXiv, abs/2407.00203, 2024. 2arxiv.org/abs/2407.00203
  6. [6]Xinheng Lyu, Yuci Liang, Wenting Chen, Meidan Ding, Jiaqi Yang, Guolin Huang, Daokun Zhang, Xiangjian He, and Linlin Shen. Wsi-agents: A collaborative multi-agent system for multi-modal whole slide image analysis. ArXiv, abs/2507.14680, 2025. 2, 6arxiv.org/abs/2507.14680
  7. [7]Yuxuan Sun, Yixuan Si, Chenglu Zhu, Kai Zhang, Zhongyi Shui, Bowen Ding, Tao Lin, and Lin Yang. Cpathagent: An agent-based foundation model for interpretable high-resolution pathology image analysis mimicking pathologists’ diagnostic logic. ArXiv, abs/2505.20510, 2025. 3arxiv.org/abs/2505.20510
  8. [8]Sheng Wang, Ruiming Wu, Charles Herndon, Yihang Liu, Shunsuke Koga, Jeanne Shen, and Zhi Huang. Pathology-cot: Learning visual chain-of-thought agent from expert whole slide image diagnosis behavior. ArXiv, abs/2510.04587, 2025.arxiv.org/abs/2510.04587
  9. [9]Jingyun Chen, Linghan Cai, Zhikang Wang, Yi Huang, Songhan Jiang, Shenjin Huang, Hongpeng Wang, and Yongbing Zhang. Pathagent: Toward interpretable analysis of whole-slide pathology images via large language model-based agentic reasoning. ArXiv, abs/2511.17052, 2025. 3arxiv.org/abs/2511.17052
  10. [10]Rundong Wang, Wei Ba, Ying Zhou, Yingtai Li, Bowen Liu, Baizhi Wang, Yuhao Wang, Zhidong Yang, Kun Zhang, Rui Yan, and S. Kevin Zhou. Qcagent: An agentic framework for quality-controllable pathology report generation from whole slide image. ArXiv, abs/2603.01647, 2026. 2arxiv.org/abs/2603.01647
  11. [11]Maximilian Ilse, Jakub M. Tomczak, and Max Welling. Attention-based deep multiple instance learning. ArXiv, abs/1802.04712, 2018. 2, 6arxiv.org/abs/1802.04712
  12. [12]Zhucheng Shao, Hao Bian, Yang Chen, Yifeng Wang, Jian Zhang, Xiangyang Ji, and Yongbing Zhang. Transmil: Transformer based correlated multiple instance learning for whole slide image classification. In Neural Information Processing Systems, 2021. 2, 6arxiv.org/abs/2106.00908
  13. [13]Yuci Liang, Xinheng Lyu, Meidan Ding, Wenting Chen, Jipeng Zhang, Yuexiang Ren, Xinjiang He, Song Wu, Sen Yang, Xiyue Wang, Xiaohan Xing, and Linlin Shen. Wsillava: A multimodal large language model for whole slide image. 2025 IEEE/CVF International Conference on Computer Vision (ICCV), pages 22718–22727, 2024. 2, 3arxiv.org/abs/2412.02141
  14. [14]Xiangru Tang, Anni Zou, Zhuosheng Zhang, Yilun Zhao, Xingyao Zhang, Arman Cohan, and Mark B. Gerstein. Medagents: Large language models as collaborators for zero-shot medical reasoning. ArXiv, abs/2311.10537, 2023. 2arxiv.org/abs/2311.10537
  15. [15]Awais Naeem, Tianhao Li, Huang-Ru Liao, Jiawei Xu, Aby Mammen Mathew, Zehao Zhu, Zhen Tan, Ajay Kumar Jaiswal, Raffi Salibian, Ziniu Hu, Tianlong Chen, and Ying Ding. Path-rag: Knowledge-guided key region retrieval for open-ended pathology visual question answering. ArXiv, abs/2411.17073, 2024. 2arxiv.org/abs/2411.17073
  16. [16]Rui Yan, Xueyuan Zhang, Zihang Jiang, Baizhi Wang, Xiuwu Bian, Fei Ren, and Iee S. Kevin Zhou Fellow. Pathway-aware multimodal transformer (pamt): Integrating pathological image and gene expression for interpretable cancer survival analysis. IEEE Transactions on Pattern Analysis and Machine Intelligence, 48:896–913, 2025. 2DOI
  17. [17]Yingxue Xu, Yihui Wang, Fengtao Zhou, Jiabo Ma, Cheng Jin, Shu Yang, Jinbang Li, Zhengyu Zhang, Chenglong Zhao, Huajun Zhou, Zhenhui Li, Huangjing Lin, Xin Wang, Jiguang Wang, Anjia Han, Ronald Cheong Kin Chan, Li Liang, Xiu-Feng Zhang, and Hao Chen. A multimodal knowledge-enhanced whole-slide pathology foundation model. Nature Communications, 16, 2024. 2arxiv.org/abs/2407.15362
  18. [18]Guolin Huang, Wenting Chen, Yiqi Yang, Xinheng Lyu, Xiaoling Luo, Sen Yang, Xiaohan Xing, and Linlin Shen. Survagent: Hierarchical cot-enhanced case banking and dichotomy-based multi-agent system for multimodal survival prediction. ArXiv, abs/2511.16635, 2025. 2, 3arxiv.org/abs/2511.16635
  19. [19]Guillaume Jaume, Anurag Vaidya, Richard J. Chen, Drew F. K. Williamson, Paul Pu Liang, and Faisal Mahmood. Modeling semi-supervised multimodal interactions between biological pathways and histology for survival prediction. 2024 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), pages 11579–11590, 2023. 6DOI
  20. [20]Richard J. Chen, Ming Y. Lu, Wei-Hung Weng, Tiffany Y. Chen, Drew F. K. Williamson, Trevor Manz, Maha Shady, and Faisal Mahmood. Multimodal co-attention transformer for survival prediction in gigapixel whole slide images. 2021 IEEE/CVF International Conference on Computer Vision (ICCV), pages 3995–4005, 2021. 2, 6DOI
  21. [21]Xiaobing Hu, Yunhang Qian, Jiaquan Yu, Jingjing Liu, Peng Tang, Xiaozhong Ji, Chengming Xu, Jiawei Liu, Xiaoxiao Yan, Xinlei Yu, et al. The landscape of medical agents: A survey. Authorea Preprints, 2025. 2
  22. [22]Guibin Zhang, Xu Xu, Yanwei Yue, Z.Y. Su, Wangchunshu Zhou, Xiaobihn Hu, and Shuicheng Yan. Onpd-evolver: Cultivating holistic agent evolver via on-policy distillation. 2026. 2DOI
  23. [23]Qianhan Feng, Zhongzhen Huang, Yakun Zhu, Yannian Gu, Winnie Chiu-Wing Chu, Xiaofan Zhang, and Qi Dou. Med-expm: Adapting experience memory for differential diagnosis. 2026.
  24. [24]Zouying Cao, Jiaji Deng, Li Yu, Wei Zhou, Zhaoyang Liu, Bolin Ding, and Haiquan Zhao. Remember me, refine me: A dynamic procedural memory framework for experience-driven agent evolution. ArXiv, abs/2512.10696, 2025. 2arxiv.org/abs/2512.10696
  25. [25]Ming Y. Lu, Bowen Chen, Drew F. K. Williamson, Richard J. Chen, Ivy Liang, Tong Ding, Guillaume Jaume, Igor Odintsov, Long Phi Le, Georg K. Gerber, Anil V Parwani, Andrew Zhang, and Faisal Mahmood. A visual-language foundation model for computational pathology. Nature medicine, 30:863 – 874, 2024. 3, 4DOI
  26. [26]Jinxi Xiang, Xiyue Wang, Xiaoming Zhang, Yin Xi, Feyisop e R. Eweje, Yijiang Chen, Yuchen Li, Colin P. Bergstrom, Matthew Gopaulchan, Ted Kim, Kun-Hsing Yu, Sierra H. Willens, Francesca Maria Olguin, Jeffrey J. Nirschl, Joel W. Neal, Maximilian Diehn, Sen Yang, and Ruijiang Li. A vision-language foundation model for precision oncology. Nature, 638:769 – 778, 2025. 3DOI
  27. [27]Zhi Huang, Federico Bianchi, Mert Yuksekgonul, Thomas Jude Montine, and James Y Zou. A visual-language foundation model for pathology image analysis using medical twitter. Nature Medicine, 29:2307–2316, 2023. 3DOI
  28. [28]Mehmet Saygin Seyfioglu, Wisdom Oluchi Ikezegwo, Fatemeh Ghezloo, Ranjay Krishna, and Linda G. Shapiro. Quilt-vlm: Visual instruction tuning by extracting localized narratives from open-source histopathology videos. 2024 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), pages 13183–13192, 2023. 3arxiv.org/abs/2312.04746
  29. [29]Yuxuan Yang, Zhonghao Yan, Yi Zhang, Boxiang Yun, Muxi Diao, Guowei Zhao, Kongming Liang, Wenbin Li, and Zhanyu Ma. Hepato-llava: An expert mlm with sparse topo-pack attention for hepatocellular pathology analysis on whole slide images. ArXiv, abs/2602.19424, 2026. 3arxiv.org/abs/2602.19424
  30. [30]Ying Chen, Guoan Wang, Yuanfeng Ji, Yanjun Li, Jin Ye, Tian-Xin Li, Bin Zhang, Nana Pei, Rongshan Yu, Yu Qiao, and Junjun He. Slidechat: A large vision-language assistant for whole-slide pathology image understanding. 2025 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), pages 5134–5143, 2024. 3arxiv.org/abs/2410.11761
  31. [31]Baizhi Wang, Kun Zhang, Yuhao Wang, Yunjie Gu, Haijing Luan, Ying Zhou, Taiyuan Hu, Rundong Wang, Zhidong Yang, Zihang Jiang, Rui Yan, and S. Kevin Zhou. Wisium: Wsi summarization via dual-level semantic reconstruction. Medical image analysis, 110:103970, 2026. 3, 4DOI
  32. [32]Chengkuan Chen, Luca L. Weishaupt, Drew F. K. Williamson, Richard J. Chen, Tong Ding, Bowen Chen, Anurag Vaidya, Long Phi Le, Guillaume Jaume, Ming Y. Lu, and Faisal Mahmood. Evidence-based diagnostic reasoning with multi-agent copilot for human pathology. ArXiv, abs/2506.20964, 2025. 3arxiv.org/abs/2506.20964
  33. [33]OpenAI. Gpt-5.5 system card. Technical report, OpenAI, 2026. Accessed: 2026-07-14. 3
  34. [34]Ziyue Wang, Junde Wu, Linghan Cai, Chang Han Low, Xihong Yang, Qiaoxuan Li, and Yueming Jin. Medagent-pro: Towards evidence-based multi-modal medical diagnosis via reasoning agentic workflow. 2025. 4
  35. [35]Tong Ding, Sophia J. Wagner, Andrew H. Song, Richard J. Chen, Ming Yang Lu, Andrew Zhang, Anurag Vaidya, Guillaume Jaume, Muhammad Shaban, Ahrong Kim, Drew F. K. Williamson, Harry Robertson, Bowen Chen, Cristina Almagro-Pérez, Paul Doucet, Sharifa Sahai, Chengkuan Chen, Christina Sze-Wei Chen, Daisuke Komura, Akihiro Kawabe, Mieko Ochi, Shinya Sato, Tomoyuki Yokose, Yohei Miyagi, Shumpei Ishikawa, Georg K. Gerber, Ting-ying Peng, Long Phi Le, and Faisal Mahmood. A multi-modal whole-slide foundation model for pathology. Nature Medicine, 31:3749 – 3761, 2025. 4
  36. [36]Xiangyu Li and Ran Su. Hero: Hypothesis-driven evidence retrieval from omics for multi-task breast cancer analysis. 2026. 4arxiv.org/abs/2606.21174
  37. [37]Günter Klambauer, Thomas Unterthiner, Andreas Mayr, and Sepp Hochreiter. Self-normalizing neural networks. In Neural Information Processing Systems, 2017. 6arxiv.org/abs/1706.02515
  38. [38]Huajun Zhou, Fengtao Zhou, and Hao Chen. Cohort-individual cooperative learning for multimodal cancer survival analysis. IEEE Transactions on Medical Imaging, 44:656–667, 2024. 6arxiv.org/abs/2404.02394
  39. [39]Yingxue Xu and Hao Chen. Multimodal optimal transport-based co-attention transformer with global structure consistency for survival prediction. 2023 IEEE/CVF International Conference on Computer Vision (ICCV), pages 21184–21194, 2023. 6arxiv.org/abs/2306.08330
  40. [40]Yu Han Kim, Chanwoo Park, Hyewon Jeong, Yik Siu Chan, Xuhai Orson Xu, Daniel McDuff, Cynthia Breazeal, and Hae Won Park. Mdagents: An adaptive collaboration of llms for medical decision-making. Advances in Neural Information Processing Systems 37, 2024. 6arxiv.org/abs/2404.15155

Paper details

vlnc:W_vubb9str
Version
v1 · latest
Published
Fresh — added to the Hub within the last 30 days
Added
License
CC BY 4.0
Usage

views · 10

downloads · 0

A view counts once per browser per day, a download each time the PDF is requested.

  • Computer Science

Not recorded for this paper

View statement
Looking for related papers…
Contents